Compare OVID & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | KIDS |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.6M | 512.4M |
| IPO Year | 2017 | 2016 |
| Metric | OVID | KIDS |
|---|---|---|
| Price | $2.51 | $19.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $4.60 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 3.4M | 149.8K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.90 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,252,000.00 | ★ $98,049,000.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | $19.34 | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1181.27 | 37.95 |
| 52 Week Low | $0.41 | $14.42 |
| 52 Week High | $3.11 | $23.70 |
| Indicator | OVID | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 48.90 | 53.43 |
| Support Level | $2.23 | $15.63 |
| Resistance Level | $2.77 | $20.20 |
| Average True Range (ATR) | 0.18 | 1.13 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 29.03 | 41.32 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.